Bruce Booth
Director · 3 filings · Latest: Apr 22, 2026
Kymera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KYMR | Bruce Booth | Director | Apr 22, 2026 | Sale | $89.96 | 6,000 | $539.8K | 674,944 | |
KYMR | Bruce Booth | Director | Apr 22, 2026 | Option Exercise | $14.44 | 5,900 | $85.2K | 5,900 | |
KYMR | Bruce Booth | Director | Apr 15, 2026 | Sale | $90.04 | 5,335 | $480.4K | 674,956 | |
KYMR | Bruce Booth | Director | Apr 15, 2026 | Option Exercise | $14.18 | 2,200 | $31.2K | 2,200 | |
KYMR | Bruce Booth | Director | Apr 14, 2026 | Sale | $89.97 | 4,159 | $374.2K | 0 | |
KYMR | Bruce Booth | Director | Apr 14, 2026 | Option Exercise | $14.18 | 4,159 | $59.0K | 4,159 | |
KYMR | Bruce Booth | — | Apr 14, 2026 | Proposed Sale | $88.53 | 24,000 | $2.1M | — | |
KYMR | Bruce Booth | Director | Mar 2, 2026 | Sale | $90.13 | 81,866 | $7.4M | 675,341 |